Cardiovascular Research Center CSIC-ICCC, CIBER-BBN, Barcelona, Spain.
Tissue Eng Part A. 2013 Mar;19(5-6):593-603. doi: 10.1089/ten.TEA.2012.0073. Epub 2012 Dec 21.
In vivo testing is a mandatory last step in scaffold development. Agile longitudinal noninvasive real-time monitoring of stem cell behavior in biomaterials implanted in live animals should facilitate the development of scaffolds for tissue engineering. We report on a noninvasive bioluminescence imaging (BLI) procedure for simultaneous monitoring of changes in the expression of multiple genes to evaluate scaffold performance in vivo. Adipose tissue-derived stromal mensenchymal cells were dually labeled with Renilla red fluorescent protein and firefly green fluorescent protein chimeric reporters regulated by cytomegalovirus and tissue-specific promoters, respectively. Labeled cells were induced to differentiate in vitro and in vivo, by seeding in demineralized bone matrices (DBMs) and monitored by BLI. Imaging results were validated by RT-polymerase chain reaction and histological procedures. The proposed approach improves molecular imaging and measurement of changes in gene expression of cells implanted in live animals. This procedure, applicable to the simultaneous analysis of multiple genes from cells seeded in DBMs, should facilitate engineering of scaffolds for tissue repair.
体内测试是支架开发的强制性最后步骤。在活体内植入生物材料的干细胞行为进行敏捷的纵向非侵入实时监测,应有助于组织工程支架的开发。我们报告了一种非侵入性的生物发光成像(BLI)程序,用于同时监测多个基因表达的变化,以评估体内支架的性能。脂肪组织衍生的基质间充质细胞分别用海肾荧光蛋白和萤火虫绿色荧光蛋白嵌合报告基因标记,由巨细胞病毒和组织特异性启动子调节。标记的细胞在体外和体内诱导分化,通过在脱钙骨基质(DBM)中接种,并通过 BLI 进行监测。通过 RT-聚合酶链反应和组织学程序对成像结果进行了验证。所提出的方法改进了活体内植入细胞的分子成像和基因表达变化的测量。该程序适用于从接种在 DBM 中的细胞同时分析多个基因,应有助于组织修复支架的工程设计。